EU5 Reproductive Health Diagnostics Market Outlook to 2036 - Prenatal Screening and Reproductive Hormones and Proteins Tests

1.1 What Is This Report About?
1.2 Reproductive Health Diagnostics Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Reproductive Health Diagnostics Market, EU5, Revenue ($m), 2024-2036
2.2 Reproductive Health Diagnostics Market, EU5, Revenue ($m), 2024-2036
2.3 Reproductive Health Diagnostics Market, EU5, Volume (Units), 2024-2036
2.4 Reproductive Health Diagnostics Market, EU5, Volume (Units), 2024-2036
2.5 Reproductive Health Diagnostics Market, EU5, Company Share by Revenue ($m), 2025

3.1 Reproductive Health Diagnostics Market, France, Revenue ($m), 2024-2036
3.1.1 Prenatal Screening Market, France, Revenue ($m), by Segment, 2024-2036
3.1.2 Reproductive Hormones and Proteins Tests Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Reproductive Health Diagnostics Market, France, Volume (Units), 2024-2036
3.2.1 Prenatal Screening Market, France, Volume (Units), by Segment, 2024-2036
3.2.2 Reproductive Hormones and Proteins Tests Market, France, Volume (Units), by Segment, 2024-2036
3.3 Reproductive Health Diagnostics Market, France, Average Price ($), 2024-2036
3.4 Reproductive Health Diagnostics Market, France, Company Share by Revenue ($m), 2025

4.1 Reproductive Health Diagnostics Market, Germany, Revenue ($m), 2024-2036
4.1.1 Prenatal Screening Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.2 Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Reproductive Health Diagnostics Market, Germany, Volume (Units), 2024-2036
4.2.1 Prenatal Screening Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.2 Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Reproductive Health Diagnostics Market, Germany, Average Price ($), 2024-2036
4.4 Reproductive Health Diagnostics Market, Germany, Company Share by Revenue ($m), 2025

5.1 Reproductive Health Diagnostics Market, Italy, Revenue ($m), 2024-2036
5.1.1 Prenatal Screening Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.2 Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Reproductive Health Diagnostics Market, Italy, Volume (Units), 2024-2036
5.2.1 Prenatal Screening Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.2 Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Reproductive Health Diagnostics Market, Italy, Average Price ($), 2024-2036
5.4 Reproductive Health Diagnostics Market, Italy, Company Share by Revenue ($m), 2025

6.1 Reproductive Health Diagnostics Market, Spain, Revenue ($m), 2024-2036
6.1.1 Prenatal Screening Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.2 Reproductive Hormones and Proteins Tests Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Reproductive Health Diagnostics Market, Spain, Volume (Units), 2024-2036
6.2.1 Prenatal Screening Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.2 Reproductive Hormones and Proteins Tests Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Reproductive Health Diagnostics Market, Spain, Average Price ($), 2024-2036
6.4 Reproductive Health Diagnostics Market, Spain, Company Share by Revenue ($m), 2025

7.1 Reproductive Health Diagnostics Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Prenatal Screening Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.2 Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Reproductive Health Diagnostics Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Prenatal Screening Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.2 Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Reproductive Health Diagnostics Market, United Kingdom, Average Price ($), 2024-2036
7.4 Reproductive Health Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2025

8.1 Reproductive Health Diagnostics Market Pipeline Products
8.2 Reproductive Health Diagnostics - Pipeline Products by Stage of Development
8.3 Reproductive Health Diagnostics - Pipeline Products by Segment
8.4 Reproductive Health Diagnostics - Pipeline Products by Territory
8.5 Reproductive Health Diagnostics - Pipeline Products by Regulatory Path
8.6 Reproductive Health Diagnostics - Pipeline Products by Estimated Approval Date

9.1 Illumina Inc
9.1.1 Company Overview
9.2 Eurofins Scientific SE
9.2.1 Company Overview
9.3 Beckman Coulter Inc
9.3.1 Company Overview
9.4 Quidel Corp
9.4.1 Company Overview
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company Overview
9.6 Roche Diagnostics International Ltd
9.6.1 Company Overview
9.7 Siemens Healthineers AG
9.7.1 Company Overview
9.8 Danaher Corp
9.8.1 Company Overview
9.9 Abbott Laboratories
9.9.1 Company Overview

10.1 Corporate Communications
10.1.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.2 Oct 24, 2025: EU Invests in Umeå Research
10.1.3 Oct 23, 2025: Red Drop Secures FIT Impact Grant
10.1.4 Sep 15, 2025: Mdxhealth Completes Acquisition of Exosome Diagnostics from Bio-Techne
10.1.5 Sep 15, 2025: Major £1.9 Million Investment Brings Microscopy Facility to Birkbeck
10.2 Other Significant Developments
10.2.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.2.2 Nov 02, 2025: Virilitas Labs Selected for Innovate UK Singapore Innovation Programme
10.2.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.2.4 Oct 24, 2025: EU Invests in Umeå Research
10.2.5 Oct 23, 2025: Red Drop Secures FIT Impact Grant
10.3 Product News
10.3.1 Nov 17, 2025: ScreenCell Standardizes CTC Isolation Kits to Two Filtration Units
10.3.2 Nov 14, 2025: Scientists Invent New Method for Producing Platelet-Producing Cells from Stem Cells
10.3.3 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.3.4 Oct 30, 2025: FNCC RR Showcases Innovative Developments at All-Russian Exhibition
10.3.5 Oct 29, 2025: New C3bBbP ELISA - Hycult Biotech
10.3.6 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies
10.3.7 Sep 10, 2025: PeploBio and Biocode Partner to Launch First Validated Microclot Assay
10.3.8 Jul 15, 2025: Early Detection of Preeclampsia Could Become More Accessible Thanks to a Cardiac Biomarker
10.4 Research And Development
10.4.1 Nov 05, 2025: Skolkovo Launches Grant Support for Technological Leaders
10.4.2 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies
10.5 Strategy And Business Planning
10.5.1 Nov 17, 2025: UMA Joins Technological Platforms to Boost Innovation
10.5.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
10.5.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.5.4 Sep 10, 2025: PeploBio and Biocode Partner to Launch First Validated Microclot Assay

11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 the Analyst Consulting
11.3 Contact Us
11.4 Disclaimer

Table 1: Reproductive Health Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Table 2: Reproductive Health Diagnostics Market, EU5, Revenue ($m), USD Constant, 2024-2036
Table 3: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2024-2036
Table 4: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2024-2036
Table 5: Reproductive Health Diagnostics Market, EU5, Company Share by Revenue ($m), 2025
Table 6: Reproductive Health Diagnostics Market, France, Revenue ($m), USD Constant, 2024-2036
Table 7: Prenatal Screening Market, France, Revenue ($m), USD Constant, 2024-2036
Table 8: Reproductive Hormones and Proteins Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Table 9: Reproductive Health Diagnostics Market, France, Volume (Units), 2024-2036
Table 10: Prenatal Screening Market, France, Volume (Units), 2024-2036
Table 11: Reproductive Hormones and Proteins Tests Market, France, Volume (Units), 2024-2036
Table 12: Reproductive Health Diagnostics Market, France, Average Price ($), 2024-2036
Table 13: Reproductive Health Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Reproductive Health Diagnostics Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 15: Prenatal Screening Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 16: Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 17: Reproductive Health Diagnostics Market, Germany, Volume (Units), 2024-2036
Table 18: Prenatal Screening Market, Germany, Volume (Units), 2024-2036
Table 19: Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), 2024-2036
Table 20: Reproductive Health Diagnostics Market, Germany, Average Price ($), 2024-2036
Table 21: Reproductive Health Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Reproductive Health Diagnostics Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 23: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 24: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Table 25: Reproductive Health Diagnostics Market, Italy, Volume (Units), 2024-2036
Table 26: Prenatal Screening Market, Italy, Volume (Units), 2024-2036
Table 27: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2024-2036
Table 28: Reproductive Health Diagnostics Market, Italy, Average Price ($), 2024-2036
Table 29: Reproductive Health Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Reproductive Health Diagnostics Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 31: Prenatal Screening Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 32: Reproductive Hormones and Proteins Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Table 33: Reproductive Health Diagnostics Market, Spain, Volume (Units), 2024-2036
Table 34: Prenatal Screening Market, Spain, Volume (Units), 2024-2036
Table 35: Reproductive Hormones and Proteins Tests Market, Spain, Volume (Units), 2024-2036
Table 36: Reproductive Health Diagnostics Market, Spain, Average Price ($), 2024-2036
Table 37: Reproductive Health Diagnostics Market, Spain, Company Share by Revenue ($m), USD Constant, 2025
Table 38: Reproductive Health Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 39: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 40: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Table 41: Reproductive Health Diagnostics Market, United Kingdom, Volume (Units), 2024-2036
Table 42: Prenatal Screening Market, United Kingdom, Volume (Units), 2024-2036
Table 43: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2024-2036
Table 44: Reproductive Health Diagnostics Market, United Kingdom, Average Price ($), 2024-2036
Table 45: Reproductive Health Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025
Table 46: Reproductive Health Diagnostics Market Pipeline Products
Table 47: Reproductive Health Diagnostics - Pipeline Products by Stage of Development
Table 48: Reproductive Health Diagnostics Companies - Pipeline Products by Stage of Development
Table 49: Reproductive Health Diagnostics - Pipeline Products by Segment
Table 50: Reproductive Health Diagnostics - Pipeline Products by Territory
Table 51: Reproductive Health Diagnostics - Pipeline Products by Regulatory Path
Table 52: Reproductive Health Diagnostics - Pipeline Products by Estimated Approval Date
Table 53: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figure 1: Reproductive Health Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 2: Reproductive Health Diagnostics Market, EU5, Revenue ($m), USD Constant, 2024-2036
Figure 3: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2024-2036
Figure 4: Reproductive Health Diagnostics Market, EU5, Volume (Units), 2024-2036
Figure 5: Reproductive Health Diagnostics Market, EU5, Company Share (%), 2025
Figure 6: Reproductive Health Diagnostics Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 7: Prenatal Screening Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 8: Reproductive Hormones and Proteins Tests Market, France, Revenue ($m), USD Constant, 2024-2036
Figure 9: Reproductive Health Diagnostics Market, France, Volume (Units), 2024-2036
Figure 10: Prenatal Screening Market, France, Volume (Units), 2024-2036
Figure 11: Reproductive Hormones and Proteins Tests Market, France, Volume (Units), 2024-2036
Figure 12: Reproductive Health Diagnostics Market, France, Company Share (%), 2025
Figure 13: Reproductive Health Diagnostics Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 14: Prenatal Screening Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 15: Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 16: Reproductive Health Diagnostics Market, Germany, Volume (Units), 2024-2036
Figure 17: Prenatal Screening Market, Germany, Volume (Units), 2024-2036
Figure 18: Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), 2024-2036
Figure 19: Reproductive Health Diagnostics Market, Germany, Company Share (%), 2025
Figure 20: Reproductive Health Diagnostics Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 21: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 22: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2024-2036
Figure 23: Reproductive Health Diagnostics Market, Italy, Volume (Units), 2024-2036
Figure 24: Prenatal Screening Market, Italy, Volume (Units), 2024-2036
Figure 25: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2024-2036
Figure 26: Reproductive Health Diagnostics Market, Italy, Company Share (%), 2025
Figure 27: Reproductive Health Diagnostics Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 28: Prenatal Screening Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 29: Reproductive Hormones and Proteins Tests Market, Spain, Revenue ($m), USD Constant, 2024-2036
Figure 30: Reproductive Health Diagnostics Market, Spain, Volume (Units), 2024-2036
Figure 31: Prenatal Screening Market, Spain, Volume (Units), 2024-2036
Figure 32: Reproductive Hormones and Proteins Tests Market, Spain, Volume (Units), 2024-2036
Figure 33: Reproductive Health Diagnostics Market, Spain, Company Share (%), 2025
Figure 34: Reproductive Health Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 35: Prenatal Screening Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 36: Reproductive Hormones and Proteins Tests Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036
Figure 37: Reproductive Health Diagnostics Market, United Kingdom, Volume (Units), 2024-2036
Figure 38: Prenatal Screening Market, United Kingdom, Volume (Units), 2024-2036
Figure 39: Reproductive Hormones and Proteins Tests Market, United Kingdom, Volume (Units), 2024-2036
Figure 40: Reproductive Health Diagnostics Market, United Kingdom, Company Share (%), 2025
Figure 41: Reproductive Health Diagnostics - Pipeline Products by Stage of Development
Figure 42: Reproductive Health Diagnostics - Pipeline Products by Segment
Figure 43: Reproductive Health Diagnostics - Pipeline Products by Territory
Figure 44: Reproductive Health Diagnostics - Pipeline Products by Regulatory Path
Figure 45: Reproductive Health Diagnostics - Pipeline Products by Estimated Approval Date